Hexcel has done better than I expected on margins ahead of reacceleration in widebody production, but that outperformance doesn’t drive a big enough change in my model to fundamentally alter my valuation view. If you’re the type of investor who is less sensitive to valuation and more confident that the shares can see another run as widebody activity accelerates, there’s a case to be made for the shares. For me, though, I need a line of sight on better long-term financials or a lower entry price.
You can read the full article here:
Hexcel Continues To Execute Well Through A Challenging Period Ahead Of A Widebody Production Ramp
No comments:
Post a Comment